Company intelligence / Profile preview
Artgen Biotech
- Ownership
- Private
- Development stage
- Other
Overview
Artgen Biotech (formerly Human Stem Cell Institute) is a leading Russian biotech company with commercialized offerings in regenerative medicine, medical genetics, gene therapy drugs, tissue engineering products, and bio-insurance. It operates major biobanking businesses for cord blood and reproductive cells. The group also develops innovative therapies for orphan and socially significant diseases using proprietary platforms such as gene‐activated matrices. Some R&D programs target primary immunodeficiencies or use novel technologies like human artificial chromosomes or polysialic acid-based drugs. The company is publicly traded on the Moscow Exchange.
- Therapeutic areas
- ImmunologyOtherCardiovascularRare Diseases
- Modalities
- Gene therapyCell therapyTissue engineering productRecombinant proteinGenetic testing and counseling services
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Beyond the preview
Go deeper on Artgen Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Artgen Biotech.